Oxybutynin Chloride
Product Images NDC 50090-4728

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50090-4728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904728)

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 1)

FDA Label Image

Figure 1 (Oxybutynin Chloride Extended Release Tablets Usp 2)

This text provides information on the mean plasma concentration of R-oxybutynin measured in ng/mL. It also includes two treatment protocols involving oxybutynin chloride ER tablets and oxybutynin 5mg taken three times a day. The numbers '16', '20', and '22' likely refer to data points or measurements.*

FDA Label Image

Figure 2 (Oxybutynin Chloride Extended Release Tablets Usp 3)

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 4)

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 5)

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 6)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.